Insiders Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Real-time Estimate Cboe BZX Other stock markets 03:16:23 2024-05-15 pm EDT			5-day change	1st Jan Change
147.9 ^USD	+0.03%		-2.87%	-22.72%

May. 07	HC Wainwright Adjusts Price Target on Alnylam Pharmaceuticals to $400 From $395, Maintains Buy Rating	MT
May. 02	Alnylam Pharmaceuticals' Q1 Non-GAAP Net Loss Narrows as Revenue Increases; 2024 Outlook Affirmed	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,540,071, According to a Recent SEC Filing	Mar. 01	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $455,357, According to a Recent SEC Filing	Feb. 29	MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $272,050, According to a Recent SEC Filing	Feb. 05	MT
Alnylam Pharmaceuticals, Inc. Announces Transition of Indrani L. Franchini as Executive Vice President, Chief Legal Officer and Secretary, Effective on March 1, 2024	Jan. 19	CI
Alnylam Pharmaceuticals Insider Sold Shares Worth $5,850,000, According to a Recent SEC Filing	Dec. 29	MT
Marsha H. Fanucci Resigns from Board of Directors of Alnylam Pharmaceuticals, Inc	23-09-28	CI
Vistagen Therapeutics Hires Alnylam's Cindy Anderson to Become Finance Chief	23-08-22	MT
Insider Sell: Alnylam Pharmaceuticals	23-08-08	MT
Insider Sell: Alnylam Pharmaceuticals	23-08-04	MT
Alnylam Pharmaceuticals, Inc. Announces Management Changes, Effective October 2, 2023	23-08-03	CI
Insider Sell: Alnylam Pharmaceuticals	23-04-28	MT
Amylyx Pharmaceuticals Appoints Masako Nakamura to Head of International Markets, Asia Pacific and Latin America	23-04-21	CI
Insider Sell: Alnylam Pharmaceuticals	23-04-10	MT
Alnylam Pharmaceuticals, Inc. Appoints Peter Kellogg to Board of Directors	23-03-08	CI
Insider Sell: Alnylam Pharmaceuticals	23-03-07	MT
Insider Sell: Alnylam Pharmaceuticals	23-02-03	MT
Insider Sell: Alnylam Pharmaceuticals	23-02-03	MT
Alnylam Pharmaceuticals Names Amy Schulman Board Chair	23-01-06	MT
Alnylam Pharmaceuticals, Inc. Announces Board Changes	23-01-05	CI
Insider Sell: Alnylam Pharmaceuticals	22-11-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Insiders

Filters